BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $176,000 | -4.3% | 2,184 | 0.0% | 0.03% | -15.2% |
| Q1 2021 | $184,000 | +5.1% | 2,184 | -0.0% | 0.03% | 0.0% |
| Q4 2020 | $175,000 | -1.7% | 2,185 | -1.7% | 0.03% | -10.8% |
| Q3 2020 | $178,000 | -7.8% | 2,223 | -1.5% | 0.04% | -11.9% |
| Q2 2020 | $193,000 | +6.0% | 2,256 | 0.0% | 0.04% | -8.7% |
| Q1 2020 | $182,000 | -2.2% | 2,256 | +1.4% | 0.05% | +12.2% |
| Q4 2019 | $186,000 | -56.1% | 2,224 | -54.2% | 0.04% | -57.7% |
| Q3 2019 | $424,000 | +5.5% | 4,854 | -1.4% | 0.10% | +11.5% |
| Q2 2019 | $402,000 | -3.1% | 4,924 | -3.5% | 0.09% | -4.4% |
| Q1 2019 | $415,000 | +19.3% | 5,104 | -3.6% | 0.09% | -58.6% |
| Q4 2018 | $348,000 | -49.1% | 5,293 | -40.3% | 0.22% | -38.7% |
| Q3 2018 | $684,000 | -9.0% | 8,873 | -12.9% | 0.36% | -5.8% |
| Q2 2018 | $752,000 | +5.2% | 10,182 | -7.4% | 0.38% | +3.5% |
| Q1 2018 | $715,000 | +0.6% | 10,997 | -0.1% | 0.37% | +6.4% |
| Q4 2017 | $711,000 | +2.6% | 11,007 | -0.4% | 0.35% | +0.9% |
| Q3 2017 | $693,000 | +1.9% | 11,050 | -1.6% | 0.34% | +1.2% |
| Q2 2017 | $680,000 | +16.8% | 11,234 | +0.1% | 0.34% | +18.1% |
| Q1 2017 | $582,000 | +24.1% | 11,228 | +6.1% | 0.29% | +21.6% |
| Q4 2016 | $469,000 | -9.1% | 10,587 | -2.3% | 0.24% | -19.2% |
| Q3 2016 | $516,000 | +5.1% | 10,837 | -0.2% | 0.29% | +1.0% |
| Q2 2016 | $491,000 | +8.6% | 10,857 | -1.4% | 0.29% | +5.9% |
| Q1 2016 | $452,000 | -16.3% | 11,007 | -22.2% | 0.27% | -14.7% |
| Q4 2015 | $540,000 | +980.0% | 14,147 | +830.7% | 0.32% | +900.0% |
| Q3 2015 | $50,000 | -38.3% | 1,520 | +30.7% | 0.03% | -33.3% |
| Q2 2015 | $81,000 | +76.1% | 1,163 | +73.3% | 0.05% | +77.8% |
| Q1 2015 | $46,000 | +100.0% | 671 | +112.3% | 0.03% | +92.9% |
| Q4 2014 | $23,000 | -4.2% | 316 | -4.8% | 0.01% | -6.7% |
| Q3 2014 | $24,000 | -17.2% | 332 | -18.0% | 0.02% | -11.8% |
| Q2 2014 | $29,000 | -6.5% | 405 | -5.2% | 0.02% | -10.5% |
| Q1 2014 | $31,000 | +6.9% | 427 | +3.1% | 0.02% | +11.8% |
| Q4 2013 | $29,000 | -23.7% | 414 | -29.1% | 0.02% | -29.2% |
| Q3 2013 | $38,000 | -20.8% | 584 | -15.2% | 0.02% | -27.3% |
| Q2 2013 | $48,000 | – | 689 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |